PURA VIDA INVESTMENTS, LLC - Q3 2021 holdings

Add to watchlist

$3.29 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 274 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 51.6% .

All

			Value		Shares		↓ Weighting
	Sell	SPDR S&P 500 ETF TRput	$236,027,000	-43.4%	550,000	-43.6%	7.18%	-44.7%
	Sell	ISHARES TRput	$131,250,000	-28.5%	600,000	-25.0%	3.99%	-30.1%
	Sell	ARK ETF TRput	$44,212,000	-43.7%	400,000	-33.3%	1.34%	-44.9%
	Sell	SPDR SER TRput	$40,856,000	-13.8%	325,000	-7.1%	1.24%	-15.7%
ATRC	Sell	ATRICURE INC	$33,335,000	-25.7%	479,293	-15.2%	1.01%	-27.4%
ICUI	Sell	ICU MED INC	$31,442,000	+2.0%	134,724	-10.1%	0.96%	-0.3%
STAA	Sell	STAAR SURGICAL CO	$21,361,000	-20.8%	166,193	-6.0%	0.65%	-22.5%
ATAI	Sell	ATAI LIFE SCIENCES NV	$17,986,000	-22.6%	1,291,872	-5.8%	0.55%	-24.3%
APR	Sell	APRIA INC	$13,206,000	-32.6%	355,465	-49.2%	0.40%	-34.1%
	Sell	INTELLIA THERAPEUTICS INCcall	$12,838,000	-73.8%	95,700	-68.4%	0.39%	-74.3%
APYX	Sell	APYX MEDICAL CORPORATION	$11,870,000	+20.9%	857,018	-10.0%	0.36%	+18.0%
CDXS	Sell	CODEXIS INC	$11,076,000	+1.0%	476,170	-1.6%	0.34%	-1.2%
	Sell	DANAHER CORPORATIONput	$10,655,000	-56.9%	35,000	-62.0%	0.32%	-57.9%
	Sell	SELECT SECTOR SPDR TRput	$9,548,000	-74.7%	75,000	-75.0%	0.29%	-75.3%
TXG	Sell	10X GENOMICS INC	$9,268,000	-26.8%	63,661	-1.5%	0.28%	-28.4%
ADPT	Sell	ADAPTIVE BIOTECHNOLOGIES COR	$8,699,000	-29.7%	255,916	-15.5%	0.26%	-31.2%
PACB	Sell	PACIFIC BIOSCIENCES CALIF IN	$8,691,000	-47.3%	340,143	-27.9%	0.26%	-48.5%
LNTH	Sell	LANTHEUS HLDGS INC	$8,652,000	-41.7%	336,926	-37.2%	0.26%	-43.1%
TKNO	Sell	ALPHA TEKNOVA INC	$8,563,000	+3.1%	344,041	-1.7%	0.26%	+0.8%
GHRS	Sell	GH RESEARCH PLCordinary shares	$8,384,000	-3.5%	380,045	-5.0%	0.26%	-5.9%
	Sell	BIOGEN INCcall	$8,320,000	-19.9%	29,400	-2.0%	0.25%	-21.7%
GH	Sell	GUARDANT HEALTH INC	$8,004,000	-2.7%	64,023	-3.3%	0.24%	-4.7%
TELA	Sell	TELA BIO INC	$7,930,000	-35.0%	580,515	-23.4%	0.24%	-36.6%
IRTC	Sell	IRHYTHM TECHNOLOGIES INC	$7,613,000	-18.0%	130,000	-7.1%	0.23%	-19.7%
	Sell	VANECK ETF TRUSTput	$7,282,000	-48.9%	100,000	-48.7%	0.22%	-50.0%
SDGR	Sell	SCHRODINGER INC	$6,629,000	-50.8%	121,231	-31.9%	0.20%	-51.8%
RCM	Sell	R1 RCM INC	$6,603,000	-69.1%	300,000	-68.7%	0.20%	-69.7%
BVS	Sell	BIOVENTUS INC	$6,076,000	-36.6%	429,129	-21.2%	0.18%	-37.9%
	Sell	THERMO FISHER SCIENTIFIC INCput	$5,713,000	-74.8%	10,000	-77.8%	0.17%	-75.4%
NTLA	Sell	INTELLIA THERAPEUTICS INC	$5,642,000	-83.8%	42,059	-80.4%	0.17%	-84.1%
MSON	Sell	MISONIX INC	$5,518,000	-47.3%	218,100	-53.8%	0.17%	-48.5%
IVC	Sell	INVACARE CORP	$5,412,000	-50.7%	1,137,028	-16.5%	0.16%	-51.8%
ARYD	Sell	ARYA SCIENCES ACQU CORP IVcl a	$5,288,000	-7.8%	526,217	-1.7%	0.16%	-10.1%
RACB	Sell	RESEARCH ALLIANCE CORP II	$5,038,000	-4.5%	511,480	-1.7%	0.15%	-6.7%
LYRA	Sell	LYRA THERAPEUTICS INC	$4,867,000	+11.7%	533,417	-1.7%	0.15%	+8.8%
RCEL	Sell	AVITA MEDICAL INC	$4,470,000	-15.9%	252,246	-2.6%	0.14%	-17.6%
TPB	Sell	TURNING PT BRANDS INC	$4,367,000	-5.6%	91,449	-9.5%	0.13%	-7.6%
DNAY	Sell	CODEX DNA INC	$4,376,000	-50.3%	393,180	-1.7%	0.13%	-51.5%
CLDX	Sell	CELLDEX THERAPEUTICS INC NEW	$4,173,000	+18.8%	77,285	-26.4%	0.13%	+16.5%
	Sell	CUREVAC N Vput	$4,189,000	-55.0%	76,700	-39.5%	0.13%	-56.2%
	Sell	VIEWRAY INCcall	$3,605,000	-22.0%	500,000	-28.6%	0.11%	-23.6%
	Sell	IRHYTHM TECHNOLOGIES INCcall	$2,928,000	-81.3%	50,000	-78.8%	0.09%	-81.7%
BNGO	Sell	BIONANO GENOMICS INC	$2,750,000	-62.5%	500,000	-50.0%	0.08%	-63.2%
ARQT	Sell	ARCUTIS BIOTHERAPEUTICS INC	$2,683,000	-13.8%	112,324	-1.5%	0.08%	-15.5%
MRTX	Sell	MIRATI THERAPEUTICS INC	$2,654,000	-58.4%	15,000	-62.0%	0.08%	-59.3%
BEAM	Sell	BEAM THERAPEUTICS INC	$2,138,000	-33.6%	24,573	-1.7%	0.06%	-35.0%
FRONU	Sell	FRONTIER ACQUISITION CORPunit 03/01/2026	$2,103,000	-3.0%	213,023	-1.7%	0.06%	-4.5%
MDVL	Sell	MEDAVAIL HOLDINGS INC	$2,085,000	-87.5%	714,120	-47.6%	0.06%	-87.9%
IMGN	Sell	IMMUNOGEN INC	$1,945,000	-57.2%	343,048	-50.2%	0.06%	-58.2%
	Sell	AMICUS THERAPEUTICS INCcall	$1,879,000	-65.6%	196,800	-65.3%	0.06%	-66.5%
	Sell	AVADEL PHARMACEUTICALS PLCcall	$1,882,000	+43.2%	192,000	-1.6%	0.06%	+39.0%
CGEM	Sell	CULLINAN ONCOLOGY INC	$1,838,000	-70.4%	81,418	-66.2%	0.06%	-71.0%
SRRA	Sell	SIERRA ONCOLOGY INC	$1,614,000	+10.5%	73,633	-1.8%	0.05%	+8.9%
PMGMU	Sell	PRIVETERRA ACQUISITION CORPunit 99/99/9999	$1,584,000	-1.5%	159,468	-1.2%	0.05%	-4.0%
KURA	Sell	KURA ONCOLOGY INC	$1,560,000	-25.1%	83,266	-16.6%	0.05%	-27.7%
TVTX	Sell	TRAVERE THERAPEUTICS INC	$1,304,000	-15.2%	53,790	-49.0%	0.04%	-16.7%
CYCN	Sell	CYCLERION THERAPEUTICS INC	$1,296,000	-34.5%	422,311	-16.8%	0.04%	-37.1%
NVRO	Sell	NEVRO CORP	$1,164,000	-76.6%	10,000	-66.7%	0.04%	-77.4%
ABGI	Sell	ABG ACQUISITION CORP I	$1,161,000	-51.2%	119,228	-50.9%	0.04%	-52.7%
GOSS	Sell	GOSSAMER BIO INC	$1,132,000	+41.3%	90,077	-8.7%	0.03%	+36.0%
LOGC	Sell	LOGICBIO THERAPEUTICS INC	$1,124,000	+1.5%	245,492	-1.5%	0.03%	0.0%
PHAT	Sell	PHATHOM PHARMACEUTICALS INC	$1,046,000	-31.6%	32,575	-27.9%	0.03%	-33.3%
HSAQ	Sell	HEALTH SCIENCES ACQ CORP 2	$1,051,000	-4.5%	106,302	-1.5%	0.03%	-5.9%
VINC	Sell	VINCERX PHARMA INC	$967,000	-65.2%	59,809	-72.1%	0.03%	-66.7%
NAUT	Sell	NAUTILUS BIOTECHNOLOGY INC	$911,000	-56.4%	148,300	-28.4%	0.03%	-56.9%
KDNY	Sell	CHINOOK THERAPEUTICS INC	$928,000	-11.2%	72,698	-1.7%	0.03%	-15.2%
GNLN	Sell	GREENLANE HLDGS INCcl a	$859,000	-52.9%	362,568	-11.1%	0.03%	-54.4%
PSTX	Sell	POSEIDA THERAPEUTICS INC	$834,000	-41.8%	114,343	-20.1%	0.02%	-44.4%
	Sell	KRYSTAL BIOTECH INCput	$642,000	-24.5%	12,300	-1.6%	0.02%	-23.1%
RPTX	Sell	REPARE THERAPEUTICS INC	$581,000	-63.7%	22,143	-56.8%	0.02%	-64.0%
CYCC	Sell	CYCLACEL PHARMACEUTICALS INC	$554,000	-40.5%	105,141	-33.2%	0.02%	-41.4%
ISEE	Sell	IVERIC BIO INC	$516,000	+70.3%	31,765	-33.9%	0.02%	+77.8%
CTMX	Sell	CYTOMX THERAPEUTICS INC	$506,000	-20.7%	99,371	-1.5%	0.02%	-25.0%
TALKW	Sell	TALKSPACE INC*w exp 06/21/202	$339,000	-43.7%	440,455	-1.6%	0.01%	-47.4%
SVRA	Sell	SAVARA INC	$134,000	-20.7%	97,461	-2.0%	0.00%	-20.0%
KTRA	Exit	KINTARA THERAPEUTICS INC	$0	–	-28,180	-100.0%	-0.00%	–
LPCN	Exit	LIPOCINE INC NEW	$0	–	-54,738	-100.0%	-0.00%	–
CHAQWS	Exit	CHARDAN HEALTHCR ACQSTN 2 CO*w exp 03/05/202	$0	–	-153,960	-100.0%	-0.00%	–
	Exit	ACHIEVE LIFE SCIENCES INC	$0	–	-17,000	-100.0%	-0.01%	–
	Exit	ARCUS BIOSCIENCES INCput	$0	–	-11,100	-100.0%	-0.01%	–
	Exit	LIPOCINE INC NEWcall	$0	–	-200,000	-100.0%	-0.01%	–
	Exit	LEXICON PHARMACEUTICALS INCput	$0	–	-63,300	-100.0%	-0.01%	–
TARS	Exit	TARSUS PHARMACEUTICALS INC	$0	–	-16,686	-100.0%	-0.02%	–
LGVN	Exit	LONGEVERON INC	$0	–	-67,120	-100.0%	-0.02%	–
CLVS	Exit	CLOVIS ONCOLOGY INC	$0	–	-97,641	-100.0%	-0.02%	–
MREO	Exit	MEREO BIOPHARMA GROUP PLCads	$0	–	-196,570	-100.0%	-0.02%	–
MCRB	Exit	SERES THERAPEUTICS INC	$0	–	-30,000	-100.0%	-0.02%	–
TSHA	Exit	TAYSHA GENE THERAPIES INC	$0	–	-33,822	-100.0%	-0.02%	–
XGN	Exit	EXAGEN INC	$0	–	-51,502	-100.0%	-0.02%	–
ACHL	Exit	ACHILLES THERAPEUTICS PLCsponsored ads	$0	–	-81,126	-100.0%	-0.02%	–
YMTX	Exit	YUMANITY THERAPEUTICS INC	$0	–	-68,197	-100.0%	-0.02%	–
EXEL	Exit	EXELIXIS INC	$0	–	-51,779	-100.0%	-0.03%	–
HCAQ	Exit	HEALTHCOR CATALIO ACQU CORP	$0	–	-97,217	-100.0%	-0.03%	–
	Exit	ALTIMMUNE INCcall	$0	–	-97,500	-100.0%	-0.03%	–
FNCH	Exit	FINCH THERAPEUTICS GROUP INC	$0	–	-71,552	-100.0%	-0.03%	–
MTACU	Exit	MEDTECH ACQUISITION CORPunit 12/18/2025	$0	–	-103,944	-100.0%	-0.03%	–
EPIX	Exit	ESSA PHARMA INC	$0	–	-38,803	-100.0%	-0.04%	–
BCTG	Exit	BCTG ACQUISITION CORP	$0	–	-98,921	-100.0%	-0.04%	–
AVDL	Exit	AVADEL PHARMACEUTICALS PLCsponsored adr	$0	–	-176,206	-100.0%	-0.04%	–
	Exit	LEXICON PHARMACEUTICALS INCcall	$0	–	-300,900	-100.0%	-0.04%	–
	Exit	VAXART INCcall	$0	–	-194,500	-100.0%	-0.04%	–
CHAQ	Exit	CHARDAN HEALTHCR ACQSTN 2 CO	$0	–	-153,960	-100.0%	-0.05%	–
	Exit	COMPUGEN LTDput	$0	–	-194,900	-100.0%	-0.05%	–
	Exit	COMPUGEN LTDcall	$0	–	-248,800	-100.0%	-0.06%	–
NVAX	Exit	NOVAVAX INC	$0	–	-10,000	-100.0%	-0.07%	–
VERO	Exit	VENUS CONCEPT INC	$0	–	-686,874	-100.0%	-0.07%	–
FVAM	Exit	5 01 ACQUISITION CORP	$0	–	-215,836	-100.0%	-0.07%	–
FBRX	Exit	FORTE BIOSCIENCES INC	$0	–	-65,583	-100.0%	-0.07%	–
	Exit	PERSONALIS INCcall	$0	–	-87,500	-100.0%	-0.07%	–
GLUE	Exit	MONTE ROSA THERAPEUTICS INC	$0	–	-100,000	-100.0%	-0.07%	–
	Exit	ARCUS BIOSCIENCES INCcall	$0	–	-88,000	-100.0%	-0.08%	–
ARVN	Exit	ARVINAS INC	$0	–	-31,543	-100.0%	-0.08%	–
	Exit	TWIST BIOSCIENCE CORPput	$0	–	-20,000	-100.0%	-0.08%	–
DOCS	Exit	DOXIMITY INCcl a	$0	–	-50,000	-100.0%	-0.09%	–
	Exit	CORBUS PHARMACEUTICALS HLDGScall	$0	–	-1,702,800	-100.0%	-0.10%	–
	Exit	GLAUKOS CORPput	$0	–	-40,000	-100.0%	-0.11%	–
VERV	Exit	VERVE THERAPEUTICS INC	$0	–	-59,393	-100.0%	-0.11%	–
OMIC	Exit	SINGULAR GENOMICS SYSTEMS IN	$0	–	-156,074	-100.0%	-0.13%	–
	Exit	ESTABLISHMENT LABS HLDGS INCcall	$0	–	-48,800	-100.0%	-0.13%	–
	Exit	CORCEPT THERAPEUTICS INCcall	$0	–	-200,000	-100.0%	-0.14%	–
	Exit	NEUROCRINE BIOSCIENCES INCcall	$0	–	-47,300	-100.0%	-0.14%	–
AKYA	Exit	AKOYA BIOSCIENCES INC	$0	–	-239,566	-100.0%	-0.14%	–
CMAX	Exit	CAREMAX INC	$0	–	-361,627	-100.0%	-0.14%	–
ZNTL	Exit	ZENTALIS PHARMACEUTICALS INC	$0	–	-91,069	-100.0%	-0.15%	–
	Exit	FIBROGEN INCcall	$0	–	-195,100	-100.0%	-0.16%	–
CMLTU	Exit	CM LIFE SCIENCES III INCunit 04/30/2028	$0	–	-483,164	-100.0%	-0.16%	–
ICAD	Exit	ICAD INC	$0	–	-310,278	-100.0%	-0.17%	–
NPCE	Exit	NEUROPACE INC	$0	–	-229,264	-100.0%	-0.17%	–
REGN	Exit	REGENERON PHARMACEUTICALS	$0	–	-10,000	-100.0%	-0.17%	–
	Exit	FIBROGEN INCput	$0	–	-213,000	-100.0%	-0.18%	–
	Exit	NANOSTRING TECHNOLOGIES INCcall	$0	–	-100,000	-100.0%	-0.20%	–
	Exit	QUEST DIAGNOSTICS INCput	$0	–	-50,000	-100.0%	-0.20%	–
	Exit	ABM INDS INCput	$0	–	-150,000	-100.0%	-0.21%	–
	Exit	CLOVER HEALTH INVESTMENTS COput	$0	–	-500,000	-100.0%	-0.21%	–
CVRX	Exit	CVRX INC	$0	–	-250,000	-100.0%	-0.22%	–
CMPS	Exit	COMPASS PATHWAYS PLCsponsored ads	$0	–	-190,071	-100.0%	-0.23%	–
	Exit	ABBVIE INCcall	$0	–	-65,800	-100.0%	-0.23%	–
ZY	Exit	ZYMERGEN INC	$0	–	-214,577	-100.0%	-0.27%	–
XENT	Exit	INTERSECT ENT INC	$0	–	-531,229	-100.0%	-0.28%	–
	Exit	CUREVAC N Vcall	$0	–	-132,300	-100.0%	-0.30%	–
TALK	Exit	TALKSPACE INC	$0	–	-1,205,869	-100.0%	-0.31%	–
PROF	Exit	PROFOUND MED CORP	$0	–	-644,273	-100.0%	-0.33%	–
	Exit	PFIZER INCput	$0	–	-300,000	-100.0%	-0.37%	–
	Exit	QIAGEN NVput	$0	–	-250,000	-100.0%	-0.38%	–
	Exit	STRYKER CORPORATIONput	$0	–	-50,000	-100.0%	-0.40%	–
CMIIU	Exit	CM LIFE SCIENCES II INCunit 02/25/2028	$0	–	-1,045,043	-100.0%	-0.44%	–
LLY	Exit	LILLY ELI & CO	$0	–	-65,922	-100.0%	-0.47%	–
	Exit	PERKINELMER INCput	$0	–	-127,500	-100.0%	-0.61%	–
ORGO	Exit	ORGANOGENESIS HLDGS INC	$0	–	-1,281,600	-100.0%	-0.66%	–
	Exit	ABBOTT LABScall	$0	–	-200,000	-100.0%	-0.72%	–
	Exit	INTUITIVE SURGICAL INCcall	$0	–	-30,000	-100.0%	-0.86%	–
	Exit	HCA HEALTHCARE INCput	$0	–	-185,000	-100.0%	-1.19%	–
	Exit	INTELLIA THERAPEUTICS INCput	$0	–	-246,900	-100.0%	-1.24%	–
INOV	Exit	INOVALON HLDGS INC	$0	–	-1,604,973	-100.0%	-1.70%	–
	Exit	MEDTRONIC PLCput	$0	–	-500,000	-100.0%	-1.93%	–

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2021-11-15

Signatures

The EDGAR filing(s) were signed by:

Alyssa Romano — Chief Financial Officer and Chief Compliance Officer

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
ICU MED INC	26	Q2 2023	4.2%
NANOSTRING TECHNOLOGIES INC	26	Q2 2023	3.3%
VIEWRAY INC	25	Q2 2023	3.2%
LIVANOVA PLC	23	Q3 2023	3.8%
ALEXION PHARMACEUTICALS INC	23	Q1 2021	4.3%
INSPIRE MED SYS INC	22	Q3 2023	3.7%
BOSTON SCIENTIFIC CORP	22	Q3 2022	4.8%
INVACARE CORP	22	Q3 2021	2.8%
ESTABLISHMENT LABS HLDGS INC	21	Q3 2023	5.0%
INTERSECT ENT INC	21	Q2 2021	2.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)

PURA VIDA INVESTMENTS, LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
Stryve Foods Holdings, LLC	April 19, 2023	1,470,649	5.6%
ICAD INC	March 15, 2023	1,277,214	5.0%
ESTABLISHMENT LABS HOLDINGS INC.	February 14, 2023	1,002,767	4.1%
Pulmonx Corp	February 14, 2023	1,216,258	3.2%
Quotient Ltd^{Sold out}	February 14, 2023	0	0.0%
Universe Pharmaceuticals INC^{Sold out}	February 14, 2023	0	0.0%
MedMen Enterprises, Inc.	April 29, 2022	139,755,072	21.4%
INVACARE CORP^{Sold out}	February 14, 2022	0	0.0%
MedAvail Holdings, Inc.	February 14, 2022	714,120	2.2%
TELA Bio, Inc.	February 14, 2022	564,120	3.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings

Type	Filed
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
SC 13G/A	2024-02-14
13F-HR	2024-02-13
SC 13D/A	2023-12-29

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export PURA VIDA INVESTMENTS, LLC's holdings